000			01851 a2200529 4500
005			20250515143926.0
264		0	_c20090106
008			200901s 0 0 eng d
022			_a1096-0341
024	7		_a10.1016/j.virol.2008.09.019 _2doi
040			_aNLM _beng _cNLM
100	1		_aFaul, Elizabeth J
245	0	0	_aInterferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. _h[electronic resource]
260			_bVirology _cDec 2008
300			_a226-38 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAIDS Vaccines _xgenetics
650	0	4	_aAdjuvants, Immunologic _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntibodies, Viral _xbiosynthesis
650	0	4	_aAntigen-Presenting Cells _ximmunology
650	0	4	_aBase Sequence
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aDNA Primers _xgenetics
650	0	4	_aGenes, gag
650	0	4	_aGenetic Vectors
650	0	4	_aHIV-1 _xgenetics
650	0	4	_aImmunity, Innate
650	0	4	_aImmunity, Mucosal
650	0	4	_aImmunoglobulin G _xbiosynthesis
650	0	4	_aInterferon Type I _xgenetics
650	0	4	_aLymphocyte Activation
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Knockout
650	0	4	_aRabies virus _xgenetics
650	0	4	_aReceptor, Interferon alpha-beta _xdeficiency
650	0	4	_aRecombinant Proteins
650	0	4	_aRecombination, Genetic
650	0	4	_aSignal Transduction
650	0	4	_aVirus Replication
700	1		_aWanjalla, Celestine N
700	1		_aMcGettigan, James P
700	1		_aSchnell, Matthias J
773	0		_tVirology _gvol. 382 _gno. 2 _gp. 226-38
856	4	0	_uhttps://doi.org/10.1016/j.virol.2008.09.019 _zAvailable from publisher's website
999			_c18408375 _d18408375